Differential activation mechanisms of serum C5a in lupus nephritis and neuropsychiatric systemic lupus erythematosus
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential activation mechanisms of serum C5a in lupus nephritis and neuropsychiatric systemic lupus erythematosus
Authors
Keywords
-
Journal
Modern Rheumatology
Volume 27, Issue 2, Pages 292-297
Publisher
Informa UK Limited
Online
2016-06-20
DOI
10.1080/14397595.2016.1193965
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thrombotic Microangiopathy in Systemic Lupus Erythematosus: Efficacy of Eculizumab
- (2015) Amr El-Husseini et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- C5a alters blood-brain barrier integrity in a humanin vitromodel of systemic lupus erythematosus
- (2015) Supriya D. Mahajan et al. IMMUNOLOGY
- Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
- (2015) Edwin K.S. Wong et al. Translational Research
- Anti-ribosomal P protein antibody induces Th1 responses by enhancing the production of IL-12 in activated monocytes
- (2014) Tatsuo Nagai et al. Modern Rheumatology
- Relationship of complement activation route with clinical manifestations in Japanese patients with systemic lupus erythematosus: A retrospective observational study
- (2014) Hiroshi Watanabe et al. Modern Rheumatology
- Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria
- (2014) Ulrike M. Reiss et al. PEDIATRIC BLOOD & CANCER
- Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus
- (2014) Shunsei Hirohata et al. ARTHRITIS RESEARCH & THERAPY
- Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus
- (2014) Shunsei Hirohata et al. ARTHRITIS RESEARCH & THERAPY
- Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
- (2013) Sean J Pittock et al. LANCET NEUROLOGY
- IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells
- (2012) Taku Yoshio et al. ARTHRITIS AND RHEUMATISM
- C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis
- (2012) Jun Yuan et al. ARTHRITIS RESEARCH & THERAPY
- C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB
- (2011) Alexander Jacob et al. JOURNAL OF NEUROCHEMISTRY
- Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis
- (2011) N Sato et al. LUPUS
- C5a alters blood-brain barrier integrity in experimental lupus
- (2010) Alexander Jacob et al. FASEB JOURNAL
- Review: Complement and its regulatory proteins in kidney diseases
- (2010) ALLISON M LESHER et al. NEPHROLOGY
- C5a, But Not C3a, Increases VEGF Secretion in ARPE-19 Human Retinal Pigment Epithelial Cells
- (2009) Daniel N. Cortright et al. CURRENT EYE RESEARCH
- Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus
- (2008) Yoshiyuki Arinuma et al. ARTHRITIS AND RHEUMATISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started